Ellen Brady, MD, MPH
Vice President, Clinical and Regulatory Research
Dr. Brady joined LTR in 2004. She is a board certified general internist with a master’s degree in public health from the Johns Hopkins School of Hygiene and Public Health. Her early career in academia focused on issues related to healthcare delivery, international health and public policy. Currently, an adjunct professorship within the University of Utah College of Pharmacy Pharmacotherapy Outcomes Research Center allows continued expression of those interests. Subsequently, and prior to LifeTech, Dr. Brady spent 20 years within the pharmaceutical industry, working for both major (Sandoz, Ciba-Geigy, Janssen Pharmaceuticals and Serono) and development-stage companies (NPS Pharmaceuticals and Esperion Therapeutics). Most recently, she was Senior Director, Clinical Research at Esperion prior to its acquisition by Pfizer.Throughout her career, she has been responsible for the clinical development of products indicated for use in cardiology, neurology, gastroenterology, endocrinology/metabolism, HIV/AIDS and asthma. Responsibilities included strategic planning around clinical development, regulatory and market issues as well as the actual design and execution of clinical trial programs. Products ranged from pre-IND to phase IV stages of development.